A comprehensive investigation on common polymorphisms in the mdr1/abcb1 transporter gene and susceptibility to colorectal cancer

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Campa, Daniele ^a,b   Sainz, Juan ^a   Pardini, Barbara ^c   Vodickova, Ludmila ^c,d   Naccarati, Alessio ^c   Rudolph, Anja ^a   Novotny, Jan ^d   Försti, Asta ^a,e   Buch, Stephan ^f   von Schönfels, Witigo ^f   Schafmayer, Clemens ^f   Völzke, Henry ^g   Hoffmeister, Michael ^a   Frank, Bernd ^a   Barale, Roberto ^b   Hemminki, Kari ^a,e   Hampe, Jochen ^f   Chang Claude, Jenny ^a   Brenner, Hermann ^a   Vodicka, Pavel ^c,d   Canzian, Federico ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF PISA   (Italy)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

^e Clinical Research Center   (Sweden)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; ATP BINDING CASSETTE B1 GENE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; CZECH REPUBLIC; DISEASE ASSOCIATION; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GERMANY; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGICAL MODEL; COLORECTAL TUMOR; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; MIDDLE AGED; RISK;

ABCB1 PROTEIN, HUMAN; GLYCOPROTEIN P;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CZECH REPUBLIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; P-GLYCOPROTEIN; POLYMORPHISM, GENETIC; RISK;

EID: 84857718978     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032784     Document Type: Article

References (67)

1. Ferlay J, Parkin DM, Steliarova-Foucher E, (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765-781.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer.
3. Andersen V, Agerstjerne L, Jensen D, Ostergaard M, Saebo M, et al. (2009) The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study. BMC Med Genet 10: 18.
4. Campa D, Pardini B, Naccarati A, Vodickova L, Novotny J, et al. (2008) A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer. Mutat Res 645: 56-60.
5. de la Chapelle A, (2004) Genetic predisposition to colorectal cancer. Nat Rev Cancer 4: 769-780.
6. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, et al. (2009) The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 125: 171-180.
7. Slattery ML, Curtin K, Anderson K, Ma KN, Ballard L, et al. (2000) Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 92: 1831-1836.
8. Carrai M, Steinke V, Vodicka P, Pardini B, Rahner N, et al. (2011) Association Between TAS2R38 Gene Polymorphisms and Colorectal Cancer Risk: A Case-Control Study in Two Independent Populations of Caucasian Origin. PLoS One 6: e20464.
9. Hughes D, Hlavata I, Soucek P, Pardini B, Naccarati A, et al. (2010) Ornithine Decarboxylase G316A Genotype and Colorectal Cancer Risk. Colorectal Dis.
10. Hughes DJ, Hlavata I, Soucek P, Pardini B, Naccarati A, et al. (2010) Variation in the Vitamin D Receptor Gene is not Associated with Risk of Colorectal Cancer in the Czech Republic. J Gastrointest Cancer.
11. Landi D, Moreno V, Guino E, Vodicka P, Pardini B, et al. (2010) Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: A review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer. Mutat Res.
12. Santarelli RL, Pierre F, Corpet DE, (2008) Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer 60: 131-144.
13. Greiner B, Eichelbaum M, Fritz P, Kreichgauer HP, von Richter O, et al. (1999) The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 104: 147-153.
14. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, et al. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A 84: 7735-7738.
15. Dietrich CG, Geier A, Oude Elferink RP, (2003) ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut 52: 1788-1795.
16. Walle UK, Walle T, (1999) Transport of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer: role of efflux pumps. Carcinogenesis 20: 2153-2157.
17. Penny JI, Campbell FC, (1994) Active transport of benzo[a]pyrene in apical membrane vesicles from normal human intestinal epithelium. Biochim Biophys Acta 1226: 232-236.
18. Phang JM, Poore CM, Lopaczynska J, Yeh GC, (1993) Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res 53: 5977-5981.
19. van Herwaarden AE, Jonker JW, Wagenaar E, Brinkhuis RF, Schellens JH, et al. (2003) The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res 63: 6447-6452.
20. Gurney H, Wong M, Balleine RL, Rivory LP, McLachlan AJ, et al. (2007) Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype. Clin Pharmacol Ther 82: 33-40.
21. Capron A, Mourad M, De Meyer M, De Pauw L, Eddour DC, et al. (2010) CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation. Pharmacogenomics 11: 703-714.
22. Buda G, Ricci D, Huang CC, Favis R, Cohen N, et al. (2010) Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin. Ann Hematol 89: 1133-1140.
23. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, et al. (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 97: 3473-3478.
24. Mickley LA, Lee JS, Weng Z, Zhan Z, Alvarez M, et al. (1998) Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood 91: 1749-1756.
25. Campa D, Gioia A, Tomei A, Poli P, Barale R, (2008) Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther 83: 559-566.
26. Panczyk M, Balcerczak E, Piaskowski S, Jamroziak K, Pasz-Walczak G, et al. (2009) ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer. Int J Colorectal Dis 24: 895-905.
27. Atalay C, Demirkazik A, Gunduz U, (2008) Role of ABCB1 and ABCC1 gene induction on survival in locally advanced breast cancer. J Chemother 20: 734-739.
28. Johnatty SE, Beesley J, Paul J, Fereday S, Spurdle AB, et al. (2008) ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy. Clin Cancer Res 14: 5594-5601.
29. Shitara K, Matsuo K, Ito S, Sawaki A, Kawai H, et al. (2010) Effects of Genetic Polymorphisms in the ABCB1 Gene on Clinical Outcomes in Patients with Gastric Cancer Treated by Second-line Chemotherapy. Asian Pac J Cancer Prev 11: 447-452.
30. Balcerczak E, Panczyk M, Piaskowski S, Pasz-Walczak G, Salagacka A, et al. (2010) ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer. Int J Colorectal Dis 25: 1167-1176.
31. Jamroziak K, Mlynarski W, Balcerczak E, Mistygacz M, Trelinska J, et al. (2004) Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol 72: 314-321.
32. De Iudicibus S, De Pellegrin A, Stocco G, Bartoli F, Bussani R, et al. (2008) ABCB1 gene polymorphisms and expression of P-glycoprotein and long-term prognosis in colorectal cancer. Anticancer Res 28: 3921-3928.
33. Kurzawski M, Drozdzik M, Suchy J, Kurzawski G, Bialecka M, et al. (2005) Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol 61: 389-394.
34. Petrova DT, Nedeva P, Maslyankov S, Toshev S, Yaramov N, et al. (2008) No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients. J Cancer Res Clin Oncol 134: 317-322.
35. Tomlinson IP, Dunlop M, Campbell H, Zanke B, Gallinger S, et al. COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer 102: 447-454.
36. Campa D, Pardini B, Naccarati A, Vodickova L, Novotny J, et al. (2010) Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study. BMC Gastroenterol 10: 112.
37. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M, Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 154: 22-30.
38. Schafmayer C, Buch S, Volzke H, von Schonfels W, Egberts JH, et al. (2009) Investigation of the colorectal cancer susceptibility region on chromosome 8q24.21 in a large German case-control sample. Int J Cancer 124: 75-80.
39. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, et al. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74: 106-120.
40. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
41. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, et al. (2005) Efficiency and power in genetic association studies. Nat Genet 37: 1217-1223.
42. Sissung TM, Baum CE, Deeken J, Price DK, Aragon-Ching J, et al. (2008) ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel. Clin Cancer Res 14: 4543-4549.
43. Lu PH, Wei MX, Yang J, Liu X, Tao GQ, et al. (2010) Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis. Breast Cancer Res Treat.
44. Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM, (2007) Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. Cancer Res 67: 9609-9612.
45. Potocnik U, Ferkolj I, Glavac D, Dean M, (2004) Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun 5: 530-539.
46. Campa D, McKay J, Sinilnikova O, Husing A, Vogel U, et al. (2009) Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk. Breast Cancer Res Treat 118: 565-574.
47. Campa D, Vodicka P, Pardini B, Naccarati A, Carrai M, et al. (2010) A gene-wide investigation on polymorphisms in the taste receptor 2R14 (TAS2R14) and susceptibility to colorectal cancer. BMC Med Genet 11: 88.
48. Sainz J, Rudolph A, Hein R, Hoffmeister M, Buch S, et al. (2011) Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk. Endocr Relat Cancer 18: 265-276.
49. Chen B, Wilkening S, Drechsel M, Hemminki K, (2009) SNP_tools: A compact tool package for analysis and conversion of genotype data for MS-Excel. BMC Res Notes 2: 214.
50. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
51. Li J, Ji L, (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95: 221-227.
52. Nyholt DR, (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74: 765-769.
53. Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, et al. (2001) Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 70: 189-199.
54. Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M, (2006) Does a negative screening colonoscopy ever need to be repeated? Gut 55: 1145-1150.
55. Ho GT, Nimmo ER, Tenesa A, Fennell J, Drummond H, et al. (2005) Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology 128: 288-296.
56. Ichihara S, Yamada Y, Kato K, Hibino T, Yokoi K, et al. (2008) Association of a polymorphism of ABCB1 with obesity in Japanese individuals. Genomics 91: 512-516.
57. Andersen V, Ostergaard M, Christensen J, Overvad K, Tjonneland A, et al. (2009) Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. BMC Cancer 9: 407.
58. Khedri A, Nejat-Shokouhi A, Salek R, Esmaeili H, Mokhtarifar A, et al. (2010) Association of the colorectal cancer and MDR1 gene polymorphism in an Iranian population. Mol Biol Rep 38: 2939-2943.
59. Osswald E, Johne A, Laschinski G, Arjomand-Nahad F, Malzahn U, et al. (2007) Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers. Eur J Clin Pharmacol 63: 9-16.
60. Bae SY, Choi SK, Kim KR, Park CS, Lee SK, et al. (2006) Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans. Cancer Sci 97: 774-779.
61. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, et al. (2007) A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315: 525-528.
62. Broderick P, Carvajal-Carmona L, Pittman AM, Webb E, Howarth K, et al. (2007) A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 39: 1315-1317.
63. Jaeger E, Webb E, Howarth K, Carvajal-Carmona L, Rowan A, et al. (2008) Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet 40: 26-28.
64. Lascorz J, Forsti A, Chen B, Buch S, Steinke V, et al. (2010) Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility. Carcinogenesis 31: 1612-1619.
65. Tenesa A, Farrington SM, Prendergast JG, Porteous ME, Walker M, et al. (2008) Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 40: 631-637.
66. Tomlinson IP, Webb E, Carvajal-Carmona L, Broderick P, Howarth K, et al. (2008) A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 40: 623-630.
67. Vineis P, Brennan P, Canzian F, Ioannidis JP, Matullo G, et al. (2008) Expectations and challenges stemming from genome-wide association studies. Mutagenesis 23: 439-444.